AAPL 186.2 -1 (-0.53%)MSFT 115.68 -1.29 (-1.10%)FB 166.03 -0.08 (-0.05%)ZNGA 5.37 -0.04 (-0.83%)NVDA 169.95 -0.19 (-0.11%)WBA 62.59 +0.41 (+0.66%)GOOG 1184.6 -10.72 (-0.90%)PIH 5.63 +1.49 (+35.99%)
AAPL 186.2 -1 (-0.53%)MSFT 115.68 -1.29 (-1.10%)FB 166.03 -0.08 (-0.05%)ZNGA 5.37 -0.04 (-0.83%)NVDA 169.95 -0.19 (-0.11%)WBA 62.59 +0.41 (+0.66%)GOOG 1184.6 -10.72 (-0.90%)PIH 5.63 +1.49 (+35.99%)

Financial Summary KALV Quote KalVista Ph

KalVista Pharmaceuticals Inc. Quote

KalVista Pharma (KALV)

28.90 -0.03 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
C
Symbol KALV
Price 28.90
Beta 2.46
Vol Avg 33.84 K
Mkt cap 104.18 M
Shares 10
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered -NaN.N
ROE -42.11% Strong Sell
ROA -27.12% Sell
Operating Margin -237.50% Strong Sell
Debt/Equity 125.93% Buy
P/E -18.06 Strong Sell
P/B 10.70 Strong Buy
Company Profile

CEO

Thomas Andrew Crockett

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ Global Market

Description

KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.